The content of lactoferrin and interleukin-8 in breast milk of patients with lactational mastitis

Nataliia Demianchuk
ID
Viorika Akimova
ID
Email src
Larysa Soyka
ID
Mariia Shchurko
ID
Lyubov Lapovets
ID
Nataliia Lutsiv
ID
Serhii Tkachuk
ID
Olha Buchko
ID
Svitlana Zubchenko
ID
Ihor Hayduchok
ID
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Communal Institution of Higher Education of Lviv Regional Council “Andrey Krupynsky Lviv Medical Academy”, Lviv, Ukraine
Communal Institution of Higher Education of Lviv Regional Council “Andrey Krupynsky Lviv Medical Academy”, Lviv, Ukraine
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Laboratory Diagnostic, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Received: 16 July 2023 / Revised: 21 November 2023 / Accepted: 9 December 2023 / Published: 30 March 2024

Abstract

Introduction and aim. Information concerning lactoferrin and interleukin-8 (IL-8) local levels in breast milk are not numerous and requires further research. The aim of this study was to determine the content of lactoferrin and interleukin-8 in the breast milk of patients with lactational mastitis, and to identify new potential markers for assessing the activity of the inflammatory process in the mammary gland.

Material and methods. This study analyzed the breast milk of 30 women with lactostasis (group I), 37 women with lactational mastitis (group II) and 30 healthy lactating women (age 26±5 years old). The milk content of lactoferrin and interleukin-8 (IL-8) was determined by enzyme-linked immunosorbent assay.

Results. The average value of lactoferrin in breast milk of healthy women was 4.78±0.47 mg/mL, exceeding levels in group I 1.8 times (p<0.05). The level of lactoferrin in group II exceeds the control values 3.1 times (p<0.05). The content of IL-8 in breast milk of women in group I was 7.3 times higher than the control (3.63±0.12 pg/mL, p<0.05). In lactational mastitis, the concentration of IL-8 in breast milk exceeded the group I 13.9 times (p<0.05) and was 1.9 times higher than group I (p<0.05).

Conclusion. The analysis has revealed an increase of lactoferrin and IL-8 in breast milk of the test groups, which indicates the activation of non-specific protection.

 

Cite

Demianchuk N, Akimova V, Soyka L, Shchurko M, Lapovets L, Lutsiv N, et al. The content of lactoferrin and interleukin-8 in breast milk of patients with lactational mastitis. Eur J Clin Exp Med. 2024;22(1):117–120. doi: 10.15584/ejcem.2024.1.22.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited